FDA APPROVED! Expected in pharmacies Q1 2023.

Full Prescribing Information
Important Safety Information
Azurity Pharmaceuticals

May 18, 2022

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

gotcha_admin Uncategorized

CONTACT US
TERMS OF USE
Privacy Policy and Cookies Notice
Web Accessibility Policy

Product labeling, packaging, and imagery are for representation purposes only.
The information contained herein, including product information, is intended only for residents of the United States.
® 2022 Azurity Pharmaceuticals, Inc. All Rights Reserved. All trademarks referred to are the property of their respective owners.

PP-KON-US-0003

Stay up-to-date on the availability of KONVOMEP^TM (omeprazole and sodium bicarbonate for oral suspension)

Register your email to receive the latest updates and information about KONVOMEP^TM delivered straight to your inbox.

First Name(Required)

Last Name(Required)

Email(Required)

Zip Code(Required)

Please select one from the list below*(Required)

I am a Pharmacist/Pharmacy Technician

I am a MD/NP/PA

Other

* Denotes mandatory fields

By clicking submit, you agree to disclose your personal information to Azurity and to be contacted by Azurity, its affiliates, and business partners in the future regarding products, services, and/or information related to KONVOMEP^TM. Azurity will not sell your information to any third party for marketing purposes without your express consent.

By clicking send, you agree to our Terms of Use and that you have read our Privacy Policy, including our Cookies Notice.